60 likes | 259 Views
The breast cancer therapeutics market in the four Asia-Pacific (APAC) countries of India, Australia, China and Japan was worth $1.5 billion in 2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.6% to $2.5 billion by 2020. Detailed report at: http://www.reportsandintelligence.com/breast-cancer-therapeutics-in-asia-pacific-to-2020-novel-her-2-positive-therapies-provide-diversified-treatment-options-market
E N D
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options Published on: May 2014 No. of Pages: 103 Reports and Intelligence
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment OptionsGBI Research, the leading business intelligence provider, has released its latest research: "Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options", which provides in-depth analysis of breast cancer market within the Asia-Pacific (APAC) covering the four countries of Australia, China, India and Japan. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis.The breast cancer therapeutics market in the four Asia-Pacific (APAC) countries of India, Australia, China and Japan was worth $1.5 billion in 2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.6% to $2.5 billion by 2020. Description
The report will enhance your decision-making capability by allowing you to - - Align your product portfolio to the markets with high growth potential - Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth - Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the breast cancer drugs market - Develop key strategic initiatives based upon an understanding of key focus areas and leading companies - Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships Reasons to buy
Table Of Content • Table of Contents • Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 –Introduction • Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Marketed Products • 4. Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Pipeline Analysis • 5. Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Market Forecast to 2020 • 6. Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Deals and Strategic Consolidations • Get full TOC at: http://www.reportsandintelligence.com/breast-cancer-therapeutics-in-asia-pacific-to-2020-novel-her-2-positive-therapies-provide-diversified-treatment-options-market/table-of-contents
Similar Reports Biosimilars - Biosimilars on the cusp of a new era http://www.bigmarketresearch.com/biosimilars-biosimilars-on-the-cusp-of-a-new-era-market Global Paediatric Vaccine Market http://www.bigmarketresearch.com/paediatric-vaccine-market
Get access to detailed information at: http://www.reportsandintelligence.com/breast-cancer-therapeutics-in-asia-pacific-to-2020-novel-her-2-positive-therapies-provide-diversified-treatment-options-market Request for Discount at: http://www.reportsandintelligence.com/purchase-enquiry/132441